Wednesday's ETF Movers: PTF, IHF
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 26 2025
0mins
Source: NASDAQ.COM
Performance of iShares U.S. Healthcare Providers ETF: The iShares U.S. Healthcare Providers ETF is underperforming, down approximately 1.5% in Wednesday afternoon trading.
Decline of Specific Stocks: Notable declines among its components include Community Health Systems, which fell by about 8.6%, and Molina Healthcare, which decreased by around 7.3%.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy MOH?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on MOH
Wall Street analysts forecast MOH stock price to rise
14 Analyst Rating
3 Buy
9 Hold
2 Sell
Hold
Current: 141.740
Low
155.00
Averages
180.85
High
250.00
Current: 141.740
Low
155.00
Averages
180.85
High
250.00
About MOH
Molina Healthcare, Inc. is a provider of managed healthcare services under the Medicaid and Medicare programs, and through the state insurance marketplaces. The Company operates through four segments: Medicaid, Medicare, Marketplace and Other. The Medicaid, Medicare, and Marketplace segments represent the government-funded or sponsored programs under which it offers managed healthcare services. Medicaid provides healthcare and long-term services and support to low-income Americans. Medicare is a federal program that provides eligible persons aged 65 and over, and some disabled persons, with a variety of hospital, medical insurance, and prescription drug benefits. The Marketplace insurance exchanges allow individuals and small groups to purchase federally subsidized health insurance. It arranges healthcare services for its members through contracts with a network of providers, including independent physicians and physician groups, hospitals, ancillary providers, and pharmacies.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
KSF Launches Investigation into Molina Healthcare
- Declining Financial Performance: Molina Healthcare reported a diluted net income of $4.75 per share for Q2 2025, an 8% year-over-year decrease, and revised its full-year 2025 adjusted earnings guidance down to no less than $19.00 per share, a 13.6% cut from previous expectations.
- Significant Net Income Reduction: The company cut its full-year 2025 GAAP net income guidance by 27% to $912 million, reflecting challenges in medical cost trends, particularly due to increased utilization of behavioral health, pharmacy, and inpatient and outpatient services.
- Securities Litigation Risk: Molina and its executives are facing a class action lawsuit for failing to disclose material information during the class period, which could further damage the company's reputation and shareholder confidence.
- Legal Investigation Initiated: Kahn Swick & Foti has commenced an investigation into whether Molina's officers and/or directors breached their fiduciary duties to shareholders or violated state or federal laws, which could lead to greater legal and financial risks for the company.
See More
ASP Isotopes Class Action Survives Dismissal Motion
- Class Action Progress: The U.S. District Court for the Southern District of New York partially denied ASP Isotopes' motion to dismiss, allowing the securities fraud class action to proceed, indicating serious consideration of investor allegations that could lead to significant financial liabilities for the company.
- False Statement Allegations: The lawsuit alleges that the company and its executives made materially false and misleading statements regarding their uranium enrichment technology prior to September 2024, raising approximately $18.6 million without actual testing, which may undermine investor confidence.
- Shareholder Rights Protection: Shareholders who purchased ASP Isotopes securities before September 26, 2024, can seek corporate reforms and fund recovery, highlighting legal avenues available for affected investors to potentially reclaim losses.
- Potential Market Impact: As the lawsuit progresses and may result in liability for the company, investor confidence in ASP Isotopes could wane, negatively impacting its stock price and reflecting market concerns over corporate governance and transparency.
See More
Americans Drop Health Insurance Coverage as Premiums Surge
- Decline in Coverage: A KFF survey reveals that approximately 9% of ACA marketplace enrollees lost their insurance after the expiration of subsidies, indicating a direct impact of rising premiums that may lead to more individuals facing healthcare cost burdens.
- Significant Premium Increases: With the lapse of enhanced premium tax credits, average premiums for ACA enrollees are expected to double by 2026, exacerbating financial pressures on households and affecting their spending capabilities.
- Voter Sentiment Shift: The survey indicates that 54% of returning ACA enrollees blame rising healthcare costs on congressional Republicans and Trump, suggesting that healthcare affordability could become a pivotal political issue in the upcoming midterm elections, influencing voter turnout.
- Household Financial Strain: About 55% of ACA enrollees report cutting back on essential expenses like food and clothing to afford healthcare costs, highlighting the profound impact of medical expenses on household finances, which could lead to higher unemployment rates and economic instability.
See More
Redwood Capital Increases Stake in Molina Healthcare
- Stake Increase: Redwood Capital increased its stake in Molina Healthcare by 51,600 shares in Q4 2026, valued at approximately $8.48 million, indicating confidence in the company despite a 53% decline in its stock price over the past year.
- Holding Position: Following this purchase, Redwood's total holdings in Molina Healthcare reached 110,000 shares, with a quarter-end value of $19.09 million, representing about 2% of Redwood's reportable U.S. equity assets.
- Financial Performance: Despite generating over $45 billion in revenue last year, Molina Healthcare's profitability sharply declined, with adjusted EPS falling to just over $11 from $22.65 the previous year due to rising medical costs and unfavorable contract dynamics.
- Market Outlook: The market anticipates a 2% decline in Molina's premium revenue for 2026, projected at around $42 billion; however, if cost pressures ease, this could present a turnaround opportunity for investors looking for defensive, policy-driven investments.
See More
JD.com Launches Joybuy to Compete with Amazon in the UK
- Market Expansion: JD.com has officially launched its Joybuy marketplace in the UK and Northern Europe, leveraging its $2.5 billion acquisition of Ceconomy to deploy 60 warehouses for same-day delivery to 15 million households, directly challenging Amazon's regional dominance and showcasing JD's ambitions in international markets.
- Price Competition: The introduction of the “JoyPlus” subscription service at just £3.99 per month significantly undercuts Amazon Prime, aiming to attract price-sensitive consumers, thereby increasing market share and enhancing customer loyalty.
- Logistics Advantage: By controlling its own last-mile delivery service and localized warehouses, JD is attempting to replicate its efficient fulfillment model from China to address domestic competitive pressures and improve overall operational efficiency.
- Electronics Market: The integration of Ceconomy provides Joybuy with an immediate foothold in the high-margin European electronics sector, expected to challenge Amazon's pricing strategies and further drive JD's growth potential in international markets.
See More
Solas Capital Management Acquires Stake in Euronet Worldwide
- New Investment Disclosure: On February 17, 2026, Solas Capital Management disclosed a new position in Euronet Worldwide by acquiring 73,494 shares valued at $5.59 million at quarter-end, reflecting confidence in the company's growth potential despite recent stock performance.
- Ownership Analysis: This investment represents 3.17% of Solas Capital Management's reportable AUM in its 13F filing, indicating a strategic diversification approach, even as Euronet's stock has declined by 30% over the past year.
- Company Performance Overview: Euronet Worldwide reported $4.24 billion in revenue for 2025, a 6% year-over-year increase, with net income reaching $309 million, showcasing robust fundamentals despite stock underperformance in the competitive payments processing sector.
- Future Growth Expectations: Management anticipates adjusted earnings per share to grow by 10% to 15% in 2026, aligning with trends in digital money transfers and international payment expansions, which may attract further investor interest in the company.
See More
KSF Launches Investigation into Molina Healthcare
- Declining Financial Performance: Molina Healthcare reported a diluted net income of $4.75 per share for Q2 2025, an 8% year-over-year decrease, and revised its full-year 2025 adjusted earnings guidance down to no less than $19.00 per share, a 13.6% cut from previous expectations.
- Significant Net Income Reduction: The company cut its full-year 2025 GAAP net income guidance by 27% to $912 million, reflecting challenges in medical cost trends, particularly due to increased utilization of behavioral health, pharmacy, and inpatient and outpatient services.
- Securities Litigation Risk: Molina and its executives are facing a class action lawsuit for failing to disclose material information during the class period, which could further damage the company's reputation and shareholder confidence.
- Legal Investigation Initiated: Kahn Swick & Foti has commenced an investigation into whether Molina's officers and/or directors breached their fiduciary duties to shareholders or violated state or federal laws, which could lead to greater legal and financial risks for the company.
See More
ASP Isotopes Class Action Survives Dismissal Motion
- Class Action Progress: The U.S. District Court for the Southern District of New York partially denied ASP Isotopes' motion to dismiss, allowing the securities fraud class action to proceed, indicating serious consideration of investor allegations that could lead to significant financial liabilities for the company.
- False Statement Allegations: The lawsuit alleges that the company and its executives made materially false and misleading statements regarding their uranium enrichment technology prior to September 2024, raising approximately $18.6 million without actual testing, which may undermine investor confidence.
- Shareholder Rights Protection: Shareholders who purchased ASP Isotopes securities before September 26, 2024, can seek corporate reforms and fund recovery, highlighting legal avenues available for affected investors to potentially reclaim losses.
- Potential Market Impact: As the lawsuit progresses and may result in liability for the company, investor confidence in ASP Isotopes could wane, negatively impacting its stock price and reflecting market concerns over corporate governance and transparency.
See More
Americans Drop Health Insurance Coverage as Premiums Surge
- Decline in Coverage: A KFF survey reveals that approximately 9% of ACA marketplace enrollees lost their insurance after the expiration of subsidies, indicating a direct impact of rising premiums that may lead to more individuals facing healthcare cost burdens.
- Significant Premium Increases: With the lapse of enhanced premium tax credits, average premiums for ACA enrollees are expected to double by 2026, exacerbating financial pressures on households and affecting their spending capabilities.
- Voter Sentiment Shift: The survey indicates that 54% of returning ACA enrollees blame rising healthcare costs on congressional Republicans and Trump, suggesting that healthcare affordability could become a pivotal political issue in the upcoming midterm elections, influencing voter turnout.
- Household Financial Strain: About 55% of ACA enrollees report cutting back on essential expenses like food and clothing to afford healthcare costs, highlighting the profound impact of medical expenses on household finances, which could lead to higher unemployment rates and economic instability.
See More
Redwood Capital Increases Stake in Molina Healthcare
- Stake Increase: Redwood Capital increased its stake in Molina Healthcare by 51,600 shares in Q4 2026, valued at approximately $8.48 million, indicating confidence in the company despite a 53% decline in its stock price over the past year.
- Holding Position: Following this purchase, Redwood's total holdings in Molina Healthcare reached 110,000 shares, with a quarter-end value of $19.09 million, representing about 2% of Redwood's reportable U.S. equity assets.
- Financial Performance: Despite generating over $45 billion in revenue last year, Molina Healthcare's profitability sharply declined, with adjusted EPS falling to just over $11 from $22.65 the previous year due to rising medical costs and unfavorable contract dynamics.
- Market Outlook: The market anticipates a 2% decline in Molina's premium revenue for 2026, projected at around $42 billion; however, if cost pressures ease, this could present a turnaround opportunity for investors looking for defensive, policy-driven investments.
See More
JD.com Launches Joybuy to Compete with Amazon in the UK
- Market Expansion: JD.com has officially launched its Joybuy marketplace in the UK and Northern Europe, leveraging its $2.5 billion acquisition of Ceconomy to deploy 60 warehouses for same-day delivery to 15 million households, directly challenging Amazon's regional dominance and showcasing JD's ambitions in international markets.
- Price Competition: The introduction of the “JoyPlus” subscription service at just £3.99 per month significantly undercuts Amazon Prime, aiming to attract price-sensitive consumers, thereby increasing market share and enhancing customer loyalty.
- Logistics Advantage: By controlling its own last-mile delivery service and localized warehouses, JD is attempting to replicate its efficient fulfillment model from China to address domestic competitive pressures and improve overall operational efficiency.
- Electronics Market: The integration of Ceconomy provides Joybuy with an immediate foothold in the high-margin European electronics sector, expected to challenge Amazon's pricing strategies and further drive JD's growth potential in international markets.
See More
Solas Capital Management Acquires Stake in Euronet Worldwide
- New Investment Disclosure: On February 17, 2026, Solas Capital Management disclosed a new position in Euronet Worldwide by acquiring 73,494 shares valued at $5.59 million at quarter-end, reflecting confidence in the company's growth potential despite recent stock performance.
- Ownership Analysis: This investment represents 3.17% of Solas Capital Management's reportable AUM in its 13F filing, indicating a strategic diversification approach, even as Euronet's stock has declined by 30% over the past year.
- Company Performance Overview: Euronet Worldwide reported $4.24 billion in revenue for 2025, a 6% year-over-year increase, with net income reaching $309 million, showcasing robust fundamentals despite stock underperformance in the competitive payments processing sector.
- Future Growth Expectations: Management anticipates adjusted earnings per share to grow by 10% to 15% in 2026, aligning with trends in digital money transfers and international payment expansions, which may attract further investor interest in the company.
See More
